The same device (matched on an identical UDI-DI) is registered in other jurisdictions. EU coverage (EUDAMED) is still phasing in — absence here does not mean a device is not marketed there.
- European UnionAptiva® APS IgA Reagent84307930407854D
Read this first: MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line shows reporting volume for the average device in the same FDA product code — a reporting baseline, not a risk measure.
No adverse-event reports are linked to this device.
No recalls linked.
- 510(k)K243979Substantially equivalent (SESE) · 2026-02-06clearance family
Predicate lineage
- K243979
Lineage each submission cites, walked transitively (indented = the cited device's own predicates). Extracted from public 510(k) summary text — heuristic, and includes reference devices mentioned alongside true predicates.
None in the loaded window.
- AESKULISA® Cardiolipin-A Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® Cardiolipin-A Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® Cardiolipin-Check Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® Cardiolipin-Check Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® Cardiolipin-GM Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® Cardiolipin-GM Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-A Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-A Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-A Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-Check Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-Check Aesku.Diagnostics GmbH & Co. KG
- AESKULISA® ß2-Glyco-Check Aesku.Diagnostics GmbH & Co. KG